futuresinbiotech.jpg Futures in Biotech

On the latest episode (#14, posted on 3/23/07) of Futures in Biotech, host Marc Pelletier talks with the founder and scientists from the Myelin Repair Foundation. The MRF is pioneering a new collaborative form of research aimed at developing treatments for multiple sclerosis, which is a disease where the myelin insulation of neurons is destroyed in an intermittent and unpredictable manner.

As of March 24, there are no show notes on the website, but I will mention that although this podcast appears fairly irregularly, it often has interviews with leading edge scientists in the biotech field. One of my favorite interviews was episode 10 with Harvard neurobiologist, Dr. Carla Shatz.

 

 

Old NID
861
Categories

Donate

Please donate so science experts can write for the public.

At Science 2.0, scientists are the journalists, with no political bias or editorial control. We can't do it alone so please make a difference.

Donate with PayPal button 
We are a nonprofit science journalism group operating under Section 501(c)(3) of the Internal Revenue Code that's educated over 300 million people.

You can help with a tax-deductible donation today and 100 percent of your gift will go toward our programs, no salaries or offices.

Latest reads

Article teaser image
Donald Trump does not have the power to rescind either constitutional amendments or federal laws by mere executive order, no matter how strongly he might wish otherwise. No president of the United…
Article teaser image
The Biden administration recently issued a new report showing causal links between alcohol and cancer, and it's about time. The link has been long-known, but alcohol carcinogenic properties have been…
Article teaser image
In British Iron Age society, land was inherited through the female line and husbands moved to live with the wife’s community. Strong women like Margaret Thatcher resulted.That was inferred due to DNA…